All are true about minimal change G.N. except ?
## Core Concept
Minimal change disease (MCD) is a type of nephrotic syndrome characterized by the loss of large amounts of protein in the urine, leading to hypoalbuminemia, hyperlipidemia, and edema. It is the most common cause of nephrotic syndrome in children. The hallmark of MCD is the absence of significant abnormalities on light microscopy, but podocyte foot process effacement is seen on electron microscopy.
## Why the Correct Answer is Right
The correct answer, ., implies that option is the statement that does not hold true for minimal change disease. Typically, MCD is known for its excellent response to corticosteroids, and it is characterized by selective proteinuria, normal complement levels, and the absence of hematuria. The pathophysiology involves immune-mediated injury to the podocytes, leading to their dysfunction.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but generally, statements about MCD being common in children, having a good response to steroids, and presenting with selective proteinuria are true.
- **Option B:** Similarly, without the content, we assume that incorrect statements might include things like MCD being associated with complement level abnormalities, significant hematuria, or poor response to steroids, which are not characteristic.
- **Option C:** As with A and B, without specifics, we consider that MCD does not typically present with hypertension or rapidly progressive renal failure as initial manifestations.
- **Option D:** This option is also not detailed, but if it suggests that MCD frequently progresses to end-stage renal disease quickly, that would be incorrect as most patients have a favorable prognosis with appropriate treatment.
## Clinical Pearl / High-Yield Fact
A key point to remember is that minimal change disease is highly responsive to corticosteroids, with most patients achieving remission within 8-12 weeks of starting treatment. This is a critical clinical pearl because it guides the management and prognosis of patients with nephrotic syndrome.
## Correct Answer: B.